2.68
price up icon12.13%   +0.29
after-market  After Hours:  2.68 
loading

CASI Pharmaceuticals Inc Stock (CASI) Forecast

The CASI Pharmaceuticals Inc (CASI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $3.0286, representing a +13.01% increase from the current price of $2.68. The highest analyst price target is $5.9796, and the lowest is $0.0776.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CASI Price Target
Average 4.5641 (+70.30% Upside)
loading

Is CASI Pharmaceuticals Inc (CASI) A Buy Now?

Oscillators
Name Value Action
RSI(14) 45.55 Neutral
STOCH(9,6) 56.75 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -0.3086 Buy
ADX(14) 32.41 Sell
William %R -12.50 Sell
CCI(14) 172.44 Buy
Buy: 2 Sell: 3 Neutral: 2
Summary: Sell
Moving Averages
Period Simple Exponential
MA10
2.4114
Buy
2.4673
Buy
MA20
2.5565
Buy
2.6401
Buy
MA50
3.5582
Sell
3.4228
Sell
MA100
4.9623
Sell
4.0212
Sell
MA200
4.0823
Sell
3.9782
Sell
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, CASI could be considered a Strong Sell, with 17 technical analysis indicators signaling 6 Buy signals, 9 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CASI, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 45.55 indicates that CASI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 56.75 indicates that CASI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that CASI is oversold. This suggests that CASI price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 32.41 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 172.44 indicates that CASI is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Long-term CASI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about CASI Pharmaceuticals Inc financial reports and earnings history, CASI Pharmaceuticals Inc (CASI) stock could reach $29.14 by 2030, $22.05 by 2040 and $66.59 by 2050. See the projected annual prices until 2050 of the CASI Pharmaceuticals Inc stock below:

  • CASI Pharmaceuticals Inc (CASI) is expected to reach an average price of $4.072 in 2035, with a high prediction of $6.5054 and a low estimate of $5.422. This indicates an $51.94% rise from the last recorded price of $2.68.
  • CASI Pharmaceuticals Inc (CASI) stock is projected to chart a bullish course in 2040, with an average price target of $22.01, representing an $721.26% surge from its current level. The forecast ranges from a conservative $22.06 to a sky-high $22.05.
  • Our analysts predict CASI Pharmaceuticals Inc (CASI) to jump 1,522% by 2045, soaring from $43.19 to an average price of $43.46, potentially reaching $43.43. While $43.19 is the low estimate, the potential upside is significant.
  • CASI Pharmaceuticals Inc (CASI) stock is expected to climb by 2050, reaching an average of $65.57, a $2,347% jump from its current level. However, a wide range of estimates exists, with high and low targets of $66.59 and $66.15, respectively, highlighting the market's uncertainty.

CASI Pharmaceuticals Inc Stock (CASI) Year by Year Forecast

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2024

Our forecast for CASI stock price in 2024 now indicates an average price target of $4.5641 with a high forecast of $9.0506 and a low forecast of $0.0776. The average prediction reflects an increase of +70.30% from the last recorded price of $2.68.
Month Average Low High Change from today's price
June, 2024 $0.8755 $0.0776 $5.9796 -67.33%
July, 2024 $1.7651 $0.1286 $3.9693 -34.14%
August, 2024 $0.7569 $0.489 $4.6589 -71.76%
September, 2024 $3.3986 $0.7548 $9.0506 +26.81%
October, 2024 $4.1382 $0.6424 $5.7702 +54.41%
November, 2024 $3.7299 $3.0299 $8.2361 +39.18%
December, 2024 $4.4216 $3.6279 $7.8237 +64.99%

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2025

CASI Pharmaceuticals Inc Stock (CASI) is expected to reach an average price of $3.8645 in 2025, with a high prediction of $7.4801 and a low estimate of $0.2488. This indicates an +44.20% rise from the last recorded price of $2.68.
Month Average Low High Change from today's price
January, 2025 $3.7113 $3.1175 $5.1154 +38.48%
February, 2025 $1.603 $1.103 $6.1071 -40.19%
March, 2025 $8.5053 $1.9991 $4.2053 +217.36%
April, 2025 $7.1156 $7.2156 $6.7074 +165.51%
May, 2025 $7.6239 $7.4198 $7.0239 +184.47%
June, 2025 $6.3322 $7.576 $7.4801 +136.28%
July, 2025 $0.6574 $0.5616 $3.4616 -75.47%
August, 2025 $1.0509 $0.2488 $1.6054 -60.79%
September, 2025 $5.1591 $3.9529 $3.7591 +92.51%
October, 2025 $7.3695 $5.1112 $6.0695 +174.98%
November, 2025 $7.7778 $7.5736 $7.0778 +190.22%
December, 2025 $0.9119 $5.2881 $7.1799 -65.98%

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2026

The predicted value for CASI Pharmaceuticals Inc (CASI) in 2026 is set at an average of $8.9042. Estimates vary from a peak of $17.78 to a trough of $0.0255, indicating an +232.25% surge from the present price of $2.68.
Month Average Low High Change from today's price
January, 2026 $2.0036 $0.8154 $7.5036 -25.24%
February, 2026 $5.6953 $0.4974 $6.1953 +112.51%
March, 2026 $12.49 $5.7932 $13.89 +365.93%
April, 2026 $6.9767 $6.2787 $17.78 +160.32%
May, 2026 $3.6684 $0.0255 $7.5746 +36.88%
June, 2026 $0.1601 $0.5399 $3.8663 -94.03%
July, 2026 $5.1503 $2.842 $3.6003 +92.17%
August, 2026 $2.2586 $2.9586 $3.2523 -15.73%
September, 2026 $4.7689 $3.8606 $3.6689 +77.94%
October, 2026 $6.5772 $5.771 $5.8772 +145.42%
November, 2026 $1.9855 $3.1855 $4.4813 -25.91%
December, 2026 $5.5958 $2.2876 $4.7958 +108.80%

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for CASI Pharmaceuticals Inc (CASI) is $7.8214, with a high forecast of $10.04 and a low forecast of $5.5979. This indicates an +191.84% increase from the last price of $2.68.
Month Average Low High Change from today's price
January, 2027 $6.2041 $5.5979 $5.5041 +131.50%
February, 2027 $7.3864 $6.4083 $5.9724 +175.61%
March, 2027 $7.5438 $7.8946 $7.5058 +181.48%
April, 2027 $8.6041 $8.0248 $7.231 +221.05%
May, 2027 $8.3983 $9.0323 $8.8352 +213.37%
June, 2027 $6.4997 $6.5497 $7.5414 +142.53%
July, 2027 $6.461 $6.461 $5.8509 +141.08%
August, 2027 $8.3673 $7.4061 $7.6663 +212.21%
September, 2027 $9.9766 $9.9303 $9.7225 +272.26%
October, 2027 $10.30 $10.23 $10.04 +284.51%
November, 2027 $9.9532 $10.11 $9.9392 +271.39%
December, 2027 $8.9236 $9.9191 $9.8653 +232.97%

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2028

In 2028, CASI Pharmaceuticals Inc (CASI) is projected to reach an average price of $7.0119, with a high projection of $9.1884 and a low estimate of $4.8354. This indicates an +161.64% rise from the last price of $2.68.
Month Average Low High Change from today's price
January, 2028 $8.2418 $8.4018 $8.1556 +207.53%
February, 2028 $9.0201 $7.746 $8.5701 +236.57%
March, 2028 $9.1605 $8.9222 $9.1884 +241.81%
April, 2028 $8.7688 $8.8688 $8.9226 +227.19%
May, 2028 $8.7291 $8.5948 $8.6008 +225.71%
June, 2028 $7.8674 $7.9574 $8.3612 +193.56%
July, 2028 $7.5357 $7.5657 $7.6795 +181.18%
August, 2028 $7.1261 $7.2161 $7.3978 +165.90%
September, 2028 $4.8843 $6.3393 $6.9831 +82.25%
October, 2028 $5.6226 $5.4128 $5.2626 +109.80%
November, 2028 $4.853 $4.913 $5.3647 +81.08%
December, 2028 $4.8113 $4.8354 $5.0971 +79.52%

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2029

The 2029 price forecast for CASI Pharmaceuticals Inc Stock (CASI) is $13.77 on average, with a high prediction of $27.52 and a low estimate of $0.0156. This represents an +413.72% increase from the previous price of $2.68.
Month Average Low High Change from today's price
January, 2029 $4.4116 $4.4634 $4.5083 +64.61%
February, 2029 $4.0199 $4.1899 $4.1158 +50.00%
March, 2029 $3.9282 $3.9582 $3.8907 +46.57%
April, 2029 $3.0265 $3.1465 $3.7503 +12.93%
May, 2029 $0.7568 $1.3155 $1.9086 -71.76%
June, 2029 $0.8249 $0.033 $0.979 -69.22%
July, 2029 $2.7866 $0.7378 $3.9107 +3.98%
August, 2029 $2.9762 $0.5504 $4.2083 +11.05%
September, 2029 $2.0579 $1.7779 $3.4042 -23.21%
October, 2029 $0.0576 $0.0397 $3.6617 -97.85%
November, 2029 $0.3607 $0.0156 $0.8834 -86.54%
December, 2029 $28.62 $0.0169 $27.52 +967.91%

CASI Pharmaceuticals Inc Stock (CASI) Price Forecast for 2030

CASI Pharmaceuticals Inc Stock (CASI) is expected to reach an average price of $28.03 in 2030, with a high forecast of $33.11 and a low forecast of $22.95. This signifies an +946.03% surge from the last price of $2.68.
Month Average Low High Change from today's price
January, 2030 $29.64 $30.33 $29.14 +1,006%
February, 2030 $28.36 $30.26 $28.55 +958.11%
March, 2030 $28.52 $28.37 $27.20 +964.32%
April, 2030 $25.89 $28.59 $28.18 +866.06%
May, 2030 $24.21 $24.61 $23.81 +803.40%
June, 2030 $23.03 $24.93 $25.22 +759.24%
July, 2030 $22.45 $23.85 $23.04 +737.63%
August, 2030 $23.26 $22.95 $22.96 +768.10%
September, 2030 $23.18 $23.62 $23.17 +764.98%
October, 2030 $31.05 $23.19 $29.20 +1,058%
November, 2030 $37.12 $32.81 $33.11 +1,285%
December, 2030 $33.50 $33.23 $31.34 +1,150%
$83.80
price up icon 0.56%
$162.01
price up icon 3.50%
$27.72
price down icon 3.58%
$150.31
price up icon 0.23%
$92.24
price up icon 2.55%
$393.42
price up icon 2.63%
Cap:     |  Volume (24h):